In brief
CMS issued the calendar year 2027 Medicare Physician Fee Schedule final rule on November 4, 2026 (CMS-1848-F). For an independent practice, five changes matter most: a baseline conversion factor cut, a same-day visit and procedure payment reduction, a redesign of the G2211 complexity add-on, tighter remote monitoring rules with a delayed vendor ban, and a new diabetes MIPS Value Pathway. The rule takes effect January 1, 2027. This post lists what changed and the questions worth settling before January.
What changed in the 2027 fee schedule?
For clinicians who do not qualify through an advanced alternative payment model, the conversion factor drops from $33.40 to $32.63, a 2.31% reduction. For qualifying APM participants, it drops from $33.57 to $32.95, a 1.83% reduction. Both cuts are steeper than the July proposed rule projected (1.68% and 1.19% respectively).
The math behind the cut: a temporary 2.5% legislative increase from 2026 expires, statutory updates add 0.75% for qualifying APM participants and 0.25% for others, and an estimated 0.12% adjustment accounts for work RVU changes. The net is a cut either way.
The rule also reduces payment by 20% for the lower-cost service when an office visit and a minor procedure happen on the same day. CMS had proposed a 50% reduction and finalized 20%. Physician groups including MGMA criticized the cuts as destabilizing for practices.
What does the conversion factor cut mean for a small practice?
A 2.31% conversion factor cut is not a 2.31% revenue cut, but for a Medicare-heavy independent practice it moves real money. The honest way to size it is to run your own top 20 billed codes against the new factor rather than rely on industry averages.
Practices built on evaluation and management visits should also look at the G2211 change below, because it partially interacts with the cut for longitudinal care.
What happens to G2211 in 2027?
G2211, the visit complexity add-on for longitudinal care relationships, stops being a flat add-on payment. It becomes a modifier that increases the payment of the associated E/M code by 16%, keeping an equal percentage increase across all levels of E/M codes.
CMS also finalized a new modifier for practitioners in Shared Savings Program ACOs or the Long-term Enhanced ACO Design model: it increases payment of the associated E/M visit by 32% to recognize longitudinal care and care coordination costs. For an endocrinology practice whose panel is mostly longitudinal chronic care, these two modifiers are worth modeling alongside the conversion factor cut, not separately.
What changes for remote monitoring?
Three things, on different clocks.
From 2027, remote therapeutic monitoring can only be furnished to established patients, and a separately reportable initiating visit is required before billing RPM or RTM services.
CMS also finalized its controversial ban on third-party RPM vendors: for billing purposes, RPM services must be performed by clinical staff employed by the practice. The agency delayed that requirement to January 1, 2029, giving practices that rely on contractors two additional years to adapt. Industry groups, providers and lawmakers had pushed back, noting that many rural, small and independent practices depend on specialized partners to offer monitoring at all.
A practice running a CGM-based monitoring program through a vendor now has a dated question: what does this program look like in 2028, and who employs the clinical staff performing it?
What is the new diabetes MVP, and when does traditional MIPS end?
The rule finalizes three new MIPS Value Pathways covering diabetes, hypertension and hospitalists, and requires clinicians to report at least one specialty-specific Core Measure starting in CY 2027. CMS says MVPs already cover approximately 98% of clinicians.
Traditional MIPS reporting officially sunsets beginning with the CY 2031 performance period. Clinicians have through CY 2030 to transition to MVPs or advanced APMs, which is two more transition years than the proposed rule offered. For an endocrinology practice, the diabetes MVP is the obvious candidate to evaluate rather than a generic reporting track.
What should an independent endocrinology practice do before January?
- Model your top 20 billed codes at the $32.63 conversion factor (or $32.95 if you qualify through an advanced APM) and compare against 2026.
- Count how often you bill an office visit and a minor procedure on the same day, and price the 20% reduction on the lower-cost service.
- Map your G2211 usage: which clinicians bill it, on which visit types, and what the 16% modifier does to those encounters.
- Inventory remote monitoring: which services depend on a third-party vendor, what changes before January 1, 2029, and where the initiating visit fits your 2027 scheduling.
- Read the diabetes MVP measure set and decide whether it fits your panel better than your current reporting track, keeping the new Core Measure requirement in view.
- If you are considering ACO participation, note the new 32% longitudinal care modifier and the option for approved ACOs to reduce Part B cost-sharing starting April 1, 2027.
Payment rules are a billing and compliance topic, so treat this post as orientation and confirm specifics with whoever owns billing for your practice.
Frequently Asked Questions
What is the 2027 Medicare conversion factor?
For clinicians not qualifying through an advanced APM, $32.63, down from $33.40, a 2.31% cut. For qualifying APM participants, $32.95, down from $33.57, a 1.83% cut. The rule takes effect January 1, 2027.
When does the RPM third-party vendor ban take effect?
January 1, 2029. CMS finalized the ban but gave practices relying on contractors two additional years. Separately, from 2027, RTM is limited to established patients and an initiating visit is required before RPM or RTM billing.
What changes with G2211 in 2027?
It converts from a flat add-on payment to a modifier that increases the associated E/M code payment by 16%, an equal percentage across E/M levels.
What is the diabetes MIPS Value Pathway?
One of three new MVPs finalized in the rule, alongside hypertension and hospitalists. It gives a diabetes-focused reporting track within MIPS, and starting in CY 2027 clinicians must report at least one specialty-specific Core Measure.
When does traditional MIPS end?
Traditional MIPS reporting sunsets with the CY 2031 performance period. Clinicians have through CY 2030 to move to an MVP or an advanced APM.
How much will the 2027 fee schedule cut cost a small practice?
It depends on your code mix, your APM status, your same-day visit and procedure billing, and your G2211 usage. The conversion factor cut is 2.31% for most non-APM clinicians, but your actual exposure needs your own numbers, not an average.
References
- HHS press release, CMS Finalizes CY 2027 Physician Fee Schedule, November 4, 2026. https://www.hhs.gov/press-room/cms-finalizes-2027-medicare-physician-fee-schedule.html
- Fierce Healthcare, CMS finalizes steeper Medicare physician pay cuts for 2027, moves ahead with RPM vendor restrictions, November 4, 2026. https://www.fiercehealthcare.com/regulatory/cms-finalizes-final-medicare-rule-deeper-cuts-physician-pay-delays-rpm-restrictions-2029
- CY 2027 Medicare Physician Fee Schedule final rule, CMS-1848-F, Federal Register docket 2026-22743 (public inspection; official publication scheduled November 9, 2026). https://www.federalregister.gov/d/2026-22743